G1 Therapeutics, Inc. (GTHX)

G1 Therapeutics Revenue

G1 Therapeutics had revenue of $16.55M in the quarter ending June 30, 2024, a decrease of -60.97%. This brings the company's revenue in the last twelve months to $58.20M, down -34.73% year-over-year. In the year 2023, G1 Therapeutics had annual revenue of $82.51M with 60.84% growth.

• Revenue (ttm): $58.20M
• Revenue Growth: -34.73%
• P/S Ratio: 6.40
• Revenue / Employee: $581,950
• Employees: 100
• Market Cap: 378.17M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	82.51M	31.21M	60.84%
Dec 31, 2022	51.30M	19.83M	62.98%
Dec 31, 2021	31.48M	-13.81M	-30.49%
Dec 31, 2020	45.29M	-	-
Dec 31, 2019	-	-	-